Fulcrum Therapeutics Inc
NASDAQ:FULC
Fulcrum Therapeutics Inc
Cash from Investing Activities
Fulcrum Therapeutics Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Fulcrum Therapeutics Inc
NASDAQ:FULC
|
Cash from Investing Activities
-$36.7m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash from Investing Activities
$878m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash from Investing Activities
-$21.7B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pfizer Inc
NYSE:PFE
|
Cash from Investing Activities
-$32.3B
|
CAGR 3-Years
-96%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
Merck & Co Inc
NYSE:MRK
|
Cash from Investing Activities
-$14.1B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-9%
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash from Investing Activities
-$7.2B
|
CAGR 3-Years
-47%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-13%
|
See Also
What is Fulcrum Therapeutics Inc's Cash from Investing Activities?
Cash from Investing Activities
-36.7m
USD
Based on the financial report for Dec 31, 2023, Fulcrum Therapeutics Inc's Cash from Investing Activities amounts to -36.7m USD.
What is Fulcrum Therapeutics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-33%
The average annual Cash from Investing Activities growth rates for Fulcrum Therapeutics Inc have been 14% over the past three years , -33% over the past five years .